Avingtrans PLC Exercise of Share Options & PDMR Share Dealing (7435R)
December 13 2016 - 9:15AM
UK Regulatory
TIDMAVG
RNS Number : 7435R
Avingtrans PLC
13 December 2016
This announcement replaces the previous release made on 12
December 2016 at 4.30pm under RNS number 6167R. The previous
announcement listed the wrong admission date for the new ordinary
shares, which has been corrected to 16 December 2016. All other
information remains unchanged.
Avingtrans Plc
("Avingtrans" or the "Company" or the "Group")
Exercise of Share Options & PDMR Share Dealing
Avingtrans (AIM:AVG), a manufacturer of critical components and
associated services to the global aerospace, energy and medical
sectors announces that on 12 December 2016 the Company issued
17,000 ordinary shares of 5 pence each ("Ordinary Shares")
following the exercise of options under the Company's CSOP share
option scheme by Austen Adams, Managing Director of the Energy
& Medical Division and a PDMR of the Company, at an exercise
price of 176p per share.
The Company was subsequently notified that immediately following
the issue, Mr Adams onward sold the new Ordinary Shares at a price
of 187p per share and as a result, Mr Adams is not holding any
Ordinary Shares in the capital of the Company.
Application has been made to the London Stock Exchange for the
new Ordinary Shares to be admitted to trading on AIM, with dealings
expected to commence on 16 December 2016 ("Admission"). Upon
Admission, the new Ordinary Shares will rank pari passu in all
respects with the existing Ordinary Shares of the Company.
After Admission, the Company's total issued share capital is
18,334,888 Ordinary Shares. Avingtrans does not hold any Ordinary
Shares in treasury and therefore following Admission, the total
number of voting rights in Avingtrans will be 18,334,888.
The above figure 18,334,888 may be used by shareholders as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change to their
interest in, Avingtrans under the FSA's Disclosure Guidance and
Transparency Rules.
Enquiries:
Avingtrans plc
Steve McQuillan, CEO
Stephen King, CFO 0135 469 2391
N+1 Singer
Shaun Dobson
Lauren Kettle 020 7496 3000
Newgate Threadneedle
(Financial PR)
Adam Lloyd
Ed Treadwell 020 7653 9850
About Avingtrans
Avingtrans plc is engaged in the provision
of highly engineered components, systems and
services to the energy, medical and traffic
management industries worldwide.
Energy and medical, engaged in the design
and manufacture of safety critical equipment
for the energy, medical, science and research
communities, including oil and gas extraction
and processing equipment, nuclear process
plant, machined and fabricated pressure and
vacuum vessels and components. Also, design
and manufacture of fabricated poles and cabinets
for roadside safety cameras and rail track
signalling.
The strategy of the group, is to "buy and
build" in regulated engineering niche markets,
where we can see potential consolidation opportunities,
which can lead to significantly increased
shareholder value over the medium to long
term.
1 Details of the person discharging managerial
responsibilities / person closely associated
--- --------------------------------------------------------
a) Name Austen Adams
--- ------------------------- -----------------------------
2 Reason for the notification
--- --------------------------------------------------------
a) Position/status Managing Director, Energy
& Medical Division (PDMR)
--- ------------------------- -----------------------------
b) Initial notification Initial
/Amendment
--- ------------------------- -----------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- --------------------------------------------------------
a) Name Avingtrans plc
--- ------------------------- -----------------------------
b) LEI
--- ------------------------- -----------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- --------------------------------------------------------
a) Description of
the financial Ordinary Shares of 5p each
instrument, type
of instrument GB0009188797
Identification
code
--- ------------------------- -----------------------------
b) Nature of the Exercise of options
transaction
--- ------------------------- -----------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
--------- ----------
176p 17,000
--------- ----------
--- ------------------------- -----------------------------
d) Aggregated information N/A (individual transaction)
- Aggregated volume
- Price
--- ------------------------- -----------------------------
e) Date of the transaction 12 November 2016
--- ------------------------- -----------------------------
f) Place of the transaction Off-market transaction
--- ------------------------- -----------------------------
1 Details of the person discharging managerial
responsibilities / person closely associated
--- --------------------------------------------------------
a) Name Austen Adams
--- ------------------------- -----------------------------
2 Reason for the notification
--- --------------------------------------------------------
a) Position/status Managing Director, Energy
& Medical Division (PDMR)
--- ------------------------- -----------------------------
b) Initial notification Initial
/Amendment
--- ------------------------- -----------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- --------------------------------------------------------
a) Name Avingtrans plc
--- ------------------------- -----------------------------
b) LEI
--- ------------------------- -----------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- --------------------------------------------------------
a) Description of
the financial Ordinary Shares of 5p each
instrument, type
of instrument GB0009188797
Identification
code
--- ------------------------- -----------------------------
b) Nature of the Sale of ordinary shares
transaction
--- ------------------------- -----------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
--------- ----------
187p 17,000
--------- ----------
--- ------------------------- -----------------------------
d) Aggregated information N/A (individual transaction)
- Aggregated volume
- Price
--- ------------------------- -----------------------------
e) Date of the transaction 12 November 2016
--- ------------------------- -----------------------------
f) Place of the transaction London Stock Exchange
--- ------------------------- -----------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHTJBITMBMBBRF
(END) Dow Jones Newswires
December 13, 2016 09:15 ET (14:15 GMT)
Avingtrans (LSE:AVG)
Historical Stock Chart
From Apr 2024 to May 2024
Avingtrans (LSE:AVG)
Historical Stock Chart
From May 2023 to May 2024